Z-1004-2023 Class II Ongoing

Recalled by Agfa Healthcare NV — Mortsel, N/A

FDA device recall Z-1004-2023 was initiated by Agfa Healthcare NV on Dec 5, 2022 and is designated Class II. Reason for recall: There is a software defect that can cause issues with images. The recall status is ongoing. Affected quantity: 110 units.

Recall details

Product Type
Devices
Report Date
Feb 1, 2023
Initiation Date
Dec 5, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
110 units

Product description

Agfa HealthCare Enterprise Imaging XERO Viewer

Reason for recall

There is a software defect that can cause issues with images.

Distribution pattern

Distribution throughout US OUS distribution to Australia, Belgium, Brazil, Canada, Chile, Cyprus, France, Iceland, Ireland, Italy, Kenya, Luxembourg, Netherlands, Romania, Saudi Arabia, Spain, Sweden, United Kingdom, South Africa

Code information

Affected software versions include: XERO Viewer 8.1.4.100 or higher XERO Viewer 8.2.0.000 or higher XERO Viewer 8.2.1.000 or higher UDI/DI: 05400874000710

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1004-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1004-2023. Report a data issue: hello@regdatalab.com.